“…Recently, EcN studies have been broadened as a safe chemical producer, thus leveraging its exploration for MCF. For instance, EcN has effectively produced a high titer bulk chemical of itaconic acid and high-value chemicals of p -coumaric acid, heparosan, aminobutyric acid, and 5-aminolevulinic acid (5-ALA). − Of valuable chemicals and drugs, 5-ALA is a metabolic hub crucial for heme precursor and also has received approval from the FDA as a second-generation photosensitizer and photodynamic drug for the treatment of glioma. − Biosynthesis of 5-ALA is majorly accomplished via the C4 pathway by overexpressing heterologous ALA synthase (ALAS), and CO 2 is a definitive side product. , Previous works of 5-ALA production from glucose have been integrated with the CO 2 biomitigation system by co-overexpressing RuBisCO and PRK. , However, rerouting flux from glucose into Ru5P would release additional CO 2 , indicating that CO 2 assimilation from chemical biosynthesis has not been effectively executed. , Moreover, as the strain used was E. coli BL21 or K-12, manipulating the acetate pathway was necessary to hinder a high acetate accumulation and maintain strain durability. , Hence, harnessing the acidophilic nature of EcN to express the CO 2 -fixing system and fine-tuning its artificial pathway are outright solutions for assimilating CO 2 emission during 5-ALA production.…”